Medicines List

Description

Cardifriend contains an active substance called ramipril. This belongs to a group of medicines called ACE inhibitors. Ramipril works by decreasing the production of substances that could raise blood pressure, relaxes and widens blood vessels and makes it easier for the heart to pump blood.

Indications

Cardifriend is indicated for:
– treatment of hypertension;
– treatment of renal disease:
– incipient glomerular diabetic nephropathy as defined by the presence of microalbuminuria;
– manifest glomerular diabetic nephropathy as defined by macroproteinuria in patients with at least one cardiovascular risk factor;
– manifest glomerular non diabetic nephropathyas defined by macroproteinuria ≥ 3 g/day;
– treatment of symptomatic heart failure;
– secondary prevention after acute myocardial infarction: reduction of mortality from the acute phase of myocardial infarction in patients with clinical signs of heart failure when started >48 hours following acute myocardial infarction.

Subject to medical prescription.

Concentration and pharmaceutical form: 5 mg, 10 mg tablets

Description

Co-Irbesso is a fixed-dose combination of an angiotensin-II receptor antagonist – irbesartan, and a thiazide diuretic – hydrochlorothiazide. The combination of these two ingredients has an additive antihypertensive effect which reduces blood pressure to a greater degree than either component alone.

Indications

Co-Irbesso is indicated:
– for treatment of essential hypertension;
– in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

Subject to medical prescription.

Concentrations and pharmaceutical form: 150 mg/12.5 mg, 300 mg/12.5 mg film-coated tablets

Description

Buto-Asma is a pressurized suspension for inhalation and contains the active substance salbutamol as sulphate.
Salbutamol belongs to the group of bronchodilators (drugs that dilate the bronchi, facilitate breathing and soothe coughs).

Indications

Buto-Asma is used for:
– Symptomatic treatment of bronchospasm in patients with bronchial asthma and similar conditions associated with reversible airway obstruction;
– Prevention of bronchospasm induced by exercise or exposure to allergic attack.

Subject to medical prescription.

Concentration and pharmaceutical form: 0,1 mg/dose pressurised inhalation, suspension

Description

Simvacor contains the active substance simvastatin and belongs to class of medicines called “statins”. Simvacor is a medicine used to lower levels of total cholesterol, “bad” cholesterol (LDL cholesterol), and fatty substances called triglycerides in the blood.

Indications

Hypercholesterolaemia
Simvacor is indicated for treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Treatment of homozygous familial hypercholesterolaemia (HoFH) as an adjunct to diet and other lipid-lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.

Cardiovascular prevention
Reduction of cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors and other cardioprotective therapy.

Subject to medical prescription.

Concentration and pharmaceutical form: 10 mg, 20 mg, 40 mg film-coated tablets